Skip to main content

Month: April 2026

Unyte Health Acquires Vital Links and Vital Sounds, Developers of Therapeutic Listening®

Unyte Health Acquires Vital Links and Vital SoundsThis union brings together the most respected pioneers in listening therapy.DENVER, April 10, 2026 (GLOBE NEWSWIRE) — Unyte Health, a leader in listening therapy interventions, is proud to announce that Vital Links and Vital Sounds have officially joined its growing family of clinical solutions. This union brings together the most respected pioneers in listening therapy, creating a home for a connected future for practitioners dedicated to nervous system-informed care, including sensory integration, occupational therapy, mental health, neurodevelopmental care, and more, across clinical and healthcare settings. For decades, Unyte Health, Vital Links, and Vital Sounds have shared a common heart: a deep respect for the nervous system as the foundation of healing. Bringing their...

Continue reading

Ocean Power Technologies to Participate in Water Tower Research Insights Conference on April 15, 2026

MONROE TOWNSHIP, N.J., April 10, 2026 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (NYSE American: OPTT) (“OPT” or the “Company”), today announced that Philipp Stratmann, President and CEO of Ocean Power Technologies, will participate in the upcoming Water Tower Research Insights Conference taking place on April 15, 2026, at 02:30 PM EST. The WTR Insights Conference is a virtual event designed for investors seeking direct access to company management teams and differentiated insights across innovative businesses spanning all sectors covered by Water Tower Research. Through a series of fireside chat discussions and curated post-event engagement opportunities, attendees will gain a deeper understanding of each company’s strategy, competitive positioning, and long-term growth outlook. Advance registration is encouraged to secure...

Continue reading

BitFuFu Announces March 2026 Bitcoin Production and Operational Updates

BitFuFu March 2026 Bitcoin Mining and Operational UpdateAs of March 31, 2026, BitFuFu managed 25.9 EH/s in hashrate, produced 214 BTC, operated 457 MW of total power capacity, and achieved an average fleet efficiency of 17.7 J/TH.BitFuFu Bitcoin Holdings as of March 31, 2026As of March 31, 2026, BitFuFu held 1,794 BTC.SINGAPORE, April 10, 2026 (GLOBE NEWSWIRE) — BitFuFu Inc. (“BitFuFu” or the “Company”) (NASDAQ: FUFU), a world-leading Bitcoin miner and mining services innovator, today announced its unaudited Bitcoin production and operational metrics for March 2026. “In March, we continued optimizing our mining portfolio by disposing of older-generation self-owned machines, which contributed to a modest decline in self-owned hashrate. We plan to refresh this capacity over time with newer, more energy-efficient...

Continue reading

ASP Isotopes to Host Business Update Conference Call on April 13, 2026, at 8:00 AM ET

DALLAS, April 10, 2026 (GLOBE NEWSWIRE) — ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today announced that Paul Mann, Executive Chairman and Chief Executive Officer at ASP Isotopes, will host a business update conference call and webcast on Monday, April 13, 2026, at 8:00 AM ET. Dial-in Information USA / International Toll: +1.646.968.2525USA – Toll-Free: +1.888.596.4144Canada – Toronto: +1.647.495.7514Canada – Toll-Free: +1.888.596.4144Conference ID 5073116 and press # Investors and the general public are invited to listen to a live webcast at: https://events.q4inc.com/attendee/430022486 A replay of the webcast will...

Continue reading

LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management

LifeMD expands its weight management program with the addition of Foundayo, offering eligible patients an oral alternative to injectable GLP-1 therapies through LillyDirect® NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) — LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that it is now offering Foundayo™ (orforglipron) to eligible patients through its weight management program. Foundayo, developed by Eli Lilly and Company, is a once daily oral treatment for adults with obesity or overweight with weight-related medical problems. Foundayo is available to eligible LifeMD patients through the Company’s integration with LillyDirect®, which enables prescriptions to be fulfilled and shipped directly to patients. The starting self-pay price for Foundayo is $149 per month for the initial...

Continue reading

Cumulus Media Reports Operating Results for 2025

ATLANTA, April 10, 2026 (GLOBE NEWSWIRE) — Cumulus Media Inc. (OTC: CMLS.Q) (the “Company,” “Cumulus Media,” “we,” “us,” or “our”) today announced operating results for the three months and year ended December 31, 2025. Mary G. Berner, President and Chief Executive Officer of Cumulus Media, said, “The Company’s recently announced financial restructuring marks an important step toward meaningfully reducing the debt burden that has constrained the business. Looking ahead, we remain focused on building on the core strengths of the Company to maximize value.” Operating Summary (dollars in thousands, except percentages and per share data): For the three months ended December 31, 2025, the Company reported net revenue of $188.1 million, a decrease of 14.0% from the three...

Continue reading

Wrap Lands Major Pre-Order for Over 20 Drone and Counter-Drone Systems, Advancing Expansion Across the U.K. and Europe

Purchase order from ABBS signals growing international demand for counter-UAS capabilities as public safety agencies seek scalable non-lethal response options for modern threats. MIAMI, April 10, 2026 (GLOBE NEWSWIRE) — Wrap Technologies, Inc. (NASDAQ: WRAP) (“Wrap” or the “Company”), a global leader in Non-Lethal Response (“NLR”) and public safety technology, today announced it has received a purchase order from Advanced Blast & Ballistic Systems Group (“ABBS”) for a pre-order of 20 MERLIN-1 Counter-UAS (“C-UAS”) drone systems for the U.K. public safety market. The order represents an important commercial milestone for Wrap’s expanding drone portfolio and a meaningful step toward broader market entry within the United Kingdom and Europe. The MERLIN-1 platform is being developed to address a growing operational gap in C-UAS...

Continue reading

Fluxys Belgium – Regulated information: Ordinary General Meeting on 12 May 2026

The Board of directors of Fluxys Belgium SA has the honour to invite the shareholders of the company to attend the Ordinary General Meeting to be held on Tuesday 12 May 2026 as from 2.30 pm at the BNP Event Center, Rue Royale 20, 1040 Brussels. Please find enclosed the notice of this General Meeting (in Dutch or French). The other documents related to this General Meeting, as well as the integrated annual report 2025, are available on the Fluxys Belgium website.AttachmentsBijlage 1 – BijeenroepingAnnexe 1 – Convocation

Continue reading

NexLiving Communities Reports Record Q4 2025 Results and Announces Promotion of Ahmed Shethwala to Chief Financial Officer

HALIFAX, Nova Scotia, April 10, 2026 (GLOBE NEWSWIRE) — (TSXV: NXLV) – NexLiving Communities Inc. (“NexLiving” or the “Company”) announced operating and financial results for the three months and year ended December 31, 2025. Stavro Stathonikos, President & CEO commented: “Q4 capped a record year for NexLiving, with 53% growth in cash flow per share driven by the internalization of our operations and integration of acquisitions. With that work largely complete, we enter 2026 with an efficient, technology-enabled platform and a stronger base of free cash flow. Our focus this year is on unlocking value across the existing portfolio and deploying capital into accretive acquisitions to continue to compound value for our shareholders.” Summary of Results:Net operating income (“NOI”) increased by +7% to $5.3 million for the three-month...

Continue reading

NeurAxis, Inc. Announces Preferred Stock Dividend

CARMEL, Ind., April 10, 2026 (GLOBE NEWSWIRE) — NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced that on April 10, 2026, its Board of Directors declared a dividend on its Series B Preferred Stock. Holders of record of the Company’s Series B Preferred Stock (the “Series B Preferred Stock”) as of the close of business on April 21, 2026 will receive a stock dividend of the Company’s common stock, par value $0.001 per share (the “Common Stock”), for every one share of Series B Preferred Stock held. The number of shares of Common Stock to be received by each holder will be determined based on the accrued and unpaid dividends on such holder’s Series B Preferred Stock...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.